OverviewSuggest Edit

Saniona, a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain. It has a portfolio of various drug candidates in pre-clinical and clinical stages. The Company's products include Tesofensine, a triple monoamine reuptake inhibitor, which is in Phase III clinical trial to treat obesity; Tesomet, a fix-dose combination of tesofensine and metoprolol that is in Phase II clinical trials for the treatment of metabolic diseases and prader-wills syndromes; NS2359, a triple monoamine reuptake inhibitor that is in Phase II clinical trial for cocaine addiction; and CAD-1883 that is in Phase I clinical trial for ataxia/tremor.

TypePublic
Founded2011
HQBallerup, DK
Websitesaniona.com

Latest Updates

Employees (est.) (May 2021)34(+42%)
Share Price (Jun 2021)KR18.8
Cybersecurity ratingAMore

Key People/Management at Saniona

Rami Levin

Rami Levin

President and Chief Executive Officer
Jørgen Drejer

Jørgen Drejer

CSO and Founder, Board Member
Jason A. Amello

Jason A. Amello

Chief Financial Officer
Rudolf Baumgartner

Rudolf Baumgartner

Chief Medical Officer and Head of Clinical Development
Trista Morrison

Trista Morrison

Chief Communications Officer
Kyle Haraldsen

Kyle Haraldsen

Chief Technical Operations Officer
Show more

Saniona Office Locations

Saniona has offices in Ballerup, Glostrup and Waltham
Ballerup, DK (HQ)
154 Baltorpvej
Glostrup, DK
Smedeland 26B
Waltham, MA, US
10 CityPoint, 500 Totten Pond Rd #620
Show all (3)

Saniona Financials and Metrics

Saniona Revenue

Market capitalization (18-Jun-2021)

1.2b

Closing stock price (18-Jun-2021)

18.8
Saniona's current market capitalization is kr1.2 b.
Show all financial metrics

Saniona Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Saniona Online and Social Media Presence

Embed Graph

Saniona Frequently Asked Questions

  • When was Saniona founded?

    Saniona was founded in 2011.

  • Who are Saniona key executives?

    Saniona's key executives are Rami Levin, Jørgen Drejer and Jason A. Amello.

  • How many employees does Saniona have?

    Saniona has 34 employees.

  • Who are Saniona competitors?

    Competitors of Saniona include WuXi AppTec, Y-mAbs Therapeutics and Abliva.

  • Where is Saniona headquarters?

    Saniona headquarters is located at 154 Baltorpvej, Ballerup.

  • Where are Saniona offices?

    Saniona has offices in Ballerup, Glostrup and Waltham.

  • How many offices does Saniona have?

    Saniona has 3 offices.